Ashley Jones

5.2k total citations
51 papers, 1.5k citations indexed

About

Ashley Jones is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Ashley Jones has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 25 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Ashley Jones's work include Amyotrophic Lateral Sclerosis Research (28 papers), Neurogenetic and Muscular Disorders Research (23 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Ashley Jones is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (28 papers), Neurogenetic and Muscular Disorders Research (23 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Ashley Jones collaborates with scholars based in United Kingdom, United States and Netherlands. Ashley Jones's co-authors include Ammar Al‐Chalabi, Claire Troakes, Leonard H. van den Berg, Safa Al‐Sarraj, Andrew King, Ahmad Al Khleifat, P. Nigel Leigh, Martin R. Turner, Christopher E. Shaw and Aleksey Shatunov and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Ashley Jones

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ashley Jones

Since Specialization

Citations

This map shows the geographic impact of Ashley Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Jones more than expected).

Fields of papers citing papers by Ashley Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Jones. The network helps show where Ashley Jones may publish in the future.

Co-authorship network of co-authors of Ashley Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Jones. A scholar is included among the top collaborators of Ashley Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Jones. Ashley Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction 2024 ·Heliyon ·Oliver Pain, Ashley Jones, Ahmad Al Khleifat, Devika Agarwal, (unknown), (unknown), (unknown), David J. Llewellyn, Janice M. Ranson, Zhi Yao, Alfredo Iacoangeli, Ammar Al‐Chalabi	4
2	Impact of MIC Breakpoint Changes for Enterobacterales on Trends of Antibiotic Susceptibilities in An Academic Medical Center 2024 ·SHILAP Revista de lepidopterología ·David Evans, Marisa Winkler, Eileen M. Burd, Ashley Jones, (unknown), James P. Steinberg, Jesse T. Jacob	0
3	Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data 2023 ·Acta Neuropathologica Communications ·(unknown), Renata Kabiljo, (unknown), Ahmad Al Khleifat, Ashley Jones, Claire Troakes, Abigail L. Pfaff, John P. Quinn, Sulev Kõks, Richard Dobson, Patrick Schwab, Ammar Al‐Chalabi, Alfredo Iacoangeli	15
4	Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts 2022 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Rubika Balendra, Ashley Jones, Ahmad Al Khleifat, (unknown), Paul Wicks, Carolyn Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh, Ammar Al‐Chalabi	2
5	A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex 2021 ·Scientific Reports ·Ashley Jones, Alfredo Iacoangeli, (unknown), (unknown), Aleksey Shatunov, Claire Troakes, Jeremy A. Garson, Adele McCormick, Ammar Al‐Chalabi	11
6	Cross-reactive probes on Illumina DNA methylation arrays: a large study on ALS shows that a cautionary approach is warranted in interpreting epigenome-wide association studies 2020 ·NAR Genomics and Bioinformatics ·Paul J. Hop, Ramona A. J. Zwamborn, Eilís Hannon, Annelot M. Dekker, Kristel R. van Eijk, Emma Walker, Alfredo Iacoangeli, Ashley Jones, Aleksey Shatunov, Ahmad Al Khleifat, Sarah Opie-Martin, Christopher E. Shaw, Karen Morrison, Pamela J. Shaw, Russell L. McLaughlin, Orla Hardiman, Ammar Al‐Chalabi, Leonard H. van den Berg, Jonathan Mill, Jan H. Veldink	15
7	DNAscan: personal computer compatible NGS analysis, annotation and visualisation 2019 ·BMC Bioinformatics ·Alfredo Iacoangeli, Ahmad Al Khleifat, William Sproviero, Aleksey Shatunov, Ashley Jones, Sarah Morgan, Alan Pittman, Richard Dobson, Stephen Newhouse, Ammar Al‐Chalabi	14
8	C9orf72 intermediate expansions of 24–30 repeats are associated with ALS 2019 ·Acta Neuropathologica Communications ·(unknown), Alfredo Iacoangeli, Ahmad Al Khleifat, Ashley Jones, William Sproviero, Aleksey Shatunov, Sarah Opie-Martin, Karen Morrison, Pamela J. Shaw, Christopher E. Shaw, Isabella Fogh, Richard Dobson, Stephen Newhouse, Ammar Al‐Chalabi	68
9	Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·Puja R. Mehta, Ashley Jones, Sarah Opie-Martin, Aleksey Shatunov, Alfredo Iacoangeli, Ahmad Al Khleifat, Bradley Smith, Simon Topp, Karen Morrison, Pamela J. Shaw, Christopher E. Shaw, Sarah Morgan, Alan Pittman, Ammar Al‐Chalabi	29
10	Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients 2016 ·NeuroMolecular Medicine ·(unknown), Claudia Ricci, Ashley Jones, Fabio Giannini, Ammar Al‐Chalabi, Stefania Battistini	64
11	Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes 2015 ·Neurobiology of Aging ·Ashley Jones, Claire Troakes, Andrew King, Vibhu Sahni, Simone de Jong, Koen Bossers, Efterpi Papouli, Muddassar M. Mirza, Safa Al‐Sarraj, Christopher E. Shaw, Pamela J. Shaw, Janine Kirby, Jan H. Veldink, Jeffrey D. Macklis, John Powell, Ammar Al‐Chalabi	21
12	Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis 2014 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ashley Jones, Naheed Jivraj, Rubika Balendra, Caroline Murphy, Joanna Kelly, (unknown), Carolyn Young, Pamela J. Shaw, P. Nigel Leigh, Martin R. Turner, I Nick Steen, Paul McCrone, Ammar Al‐Chalabi	27
13	Neuroendocrine Merkel Cell Carcinoma Is Associated with Mutations in Key DNA Repair, Epigenetic and Apoptosis Pathways: A Case-Based Study Using Targeted Massively Parallel Sequencing 2014 ·Neuroendocrinology ·(unknown), Ashley Jones, Justin S. Reynolds, Jeremy Stuart, Lucia Pirisi, (unknown), James W. Wells	10
14	Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·Rubika Balendra, Ashley Jones, Naheed Jivraj, I Nick Steen, Carolyn Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh, Ammar Al‐Chalabi, (unknown)	71
15	Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD) 2013 ·JMIR mhealth and uhealth ·Olubunmi Abel, Aleksey Shatunov, Ashley Jones, Peter M. Andersen, John Powell, Ammar Al‐Chalabi	47
16	Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice 2013 ·Neurobiology of Disease ·Kim A. Staats, Lawrence Van Helleputte, Ashley Jones, André Bento‐Abreu, Annelies Van Hoecke, Aleksey Shatunov, Claire L. Simpson, Robin Lemmens, Tom Jaspers, Kiyoko Fukami, Yoshikazu Nakamura, Robert H. Brown, Philip Van Damme, Adrian Liston, Wim Robberecht, Ammar Al‐Chalabi, Ludo Van Den Bosch	14
17	Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat 2013 ·Neurobiology of Aging ·Ashley Jones, Ione Woollacott, Aleksey Shatunov, Johnathan Cooper‐Knock, Vladimir L. Buchman, William Sproviero, Bradley Smith, Kirsten M. Scott, Rubika Balendra, Olubunmi Abel, Peter McGuffin, C. M. Ellis, Pamela J. Shaw, Karen Morrison, Anne Farmer, Cathryn M. Lewis, P. Nigel Leigh, Christopher E. Shaw, John Powell, Ammar Al‐Chalabi	16
18	The genetics and neuropathology of amyotrophic lateral sclerosis 2012 ·Acta Neuropathologica ·Ammar Al‐Chalabi, Ashley Jones, Claire Troakes, Andrew King, Safa Al‐Sarraj, Leonard H. van den Berg	286
19	Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience 2000 ·Biology of Blood and Marrow Transplantation ·JA Russell, A Chaudhry, Karen Booth, Christopher Brown, Richard C. Woodman, (unknown), Doug Stewart, Joseph D. Ruether, Bernard A. Ruether, Ashley Jones, Max J. Coppes, Thomas J. Bowen, Richard A. Anderson, (unknown), (unknown), (unknown), (unknown)	50
20	Double autologous bone marrow transplantation for acute myelogenous leukemia in a patient treated for Hodgkin's disease 1989 ·Medical and Pediatric Oncology ·Jeffrey A. Russell, Ashley Jones, B Houwen, Man‐Chiu Poon, Bernard A. Ruether	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact